These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33853745)

  • 41. How does the clinical and tomographic appearance of MRONJ influences its treatment prognosis?
    Moreno Rabie C; García-Larraín S; Contreras Diez de Medina D; Cabello-Salazar I; Fontenele RC; Van den Wyngaert T; Jacobs R
    Dentomaxillofac Radiol; 2023 Nov; 52(8):20230304. PubMed ID: 37870051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature.
    Chehal H; Nikitakis NG; Islam MN; Goodchild JH; Mordini L; Bhattacharyya I
    Gen Dent; 2019; 67(1):42-46. PubMed ID: 30644830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
    Kuroshima S; Sasaki M; Murata H; Sawase T
    Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autofluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw (MRONJ): a retrospective single-center study.
    Otto S; Schnödt EM; Haidari S; Brunner TF; Aljohani S; Mosleh M; Ristow O; Troeltzsch M; Pautke C; Ehrenfeld M; Fliefel R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 May; 131(5):519-526. PubMed ID: 33309263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma.
    Lu SY; Ma MC; Wang MC; Hsue SS
    J Formos Med Assoc; 2021 Nov; 120(11):1967-1976. PubMed ID: 33551311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?
    Ueda N; Nakashima C; Aoki K; Shimotsuji H; Nakaue K; Yoshioka H; Kurokawa S; Imai Y; Kirita T
    Clin Oral Investig; 2021 May; 25(5):3087-3093. PubMed ID: 33057886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study.
    Soares AL; Simon S; Gebrim LH; Nazário ACP; Lazaretti-Castro M
    Support Care Cancer; 2020 May; 28(5):2265-2271. PubMed ID: 31468192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Risk assessment of bisphosphonate-related osteonecrosis of the jaw based on CBCT scans].
    Koppány F; Joób-Fancsaly Á; Németh Z; Belik AA; Vaszilkó M; Varmuzsa EM; Csomó KB
    Orv Hetil; 2020 May; 161(21):867-872. PubMed ID: 32427571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.
    Otsuru M; Hayashida S; Morishita K; Murata M; Soutome S; Sasaki M; Takagi Y; Sumi M; Umeda M
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-Sectional Study of four Serological Bone Turnover Markers for the Risk Assessment of Medication-Related Osteonecrosis of the Jaw.
    Peisker A; Raschke GF; Fahmy MD; Guentsch A; Roshanghias K; König KC; Schultze-Mosgau S
    J Craniofac Surg; 2018 Mar; 29(2):e137-e140. PubMed ID: 29215447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of the cone beam computed tomography findings in medication-related osteonecrosis of the jaws related to denosumab versus bisphosphonates: an observational pilot study.
    Pichardo SEC; Broek FWT; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Apr; 129(4):411-417. PubMed ID: 32001241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review.
    Khominsky A; Lim M
    Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
    Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
    J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of concentrated growth factor (CGF) in the surgical treatment of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a randomized controlled study.
    Yüce MO; Adalı E; Işık G
    Clin Oral Investig; 2021 Jul; 25(7):4529-4541. PubMed ID: 33392802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
    Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
    Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medication-related osteonecrosis of the jaw: A multifaceted diagnostic challenge. Mini review.
    Bonachea R; Katz J
    Am J Dent; 2022 Apr; 35(2):109-112. PubMed ID: 35506967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
    Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
    J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
    Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
    Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.
    Wongratwanich P; Shimabukuro K; Konishi M; Nagasaki T; Ohtsuka M; Suei Y; Nakamoto T; Verdonschot RG; Kanesaki T; Sutthiprapaporn P; Kakimoto N
    Dentomaxillofac Radiol; 2021 Sep; 50(6):20200417. PubMed ID: 33411572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pain characteristics in medication-related osteonecrosis of the jaws.
    Haviv Y; Geller Z; Mazor S; Sharav Y; Keshet N; Zadik Y
    Support Care Cancer; 2021 Feb; 29(2):1073-1080. PubMed ID: 32601851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.